OGN and type 2 diabetes mellitus: Analysis of the total average of osteoglycin-positive cells using immunohistochemistry revealed no significant differences in osteoglycin expression in calcified vessels from patients with T2D compared with noncalcified vessels from control subjects (136.5 ± 46.3 vs. 100.8 ± 44.9, P = 0.321).